Comparison of Formulas for Calculating Low-Density Lipoprotein Cholesterol in General Population and High-Risk Patients with Cardiovascular Disease

被引:23
|
作者
Choi, Hansol [1 ,3 ]
Shim, Jee-Seon [3 ]
Lee, Myung Ha [2 ,3 ]
Yoon, Young Mi [3 ]
Choi, Dong Phil [3 ]
Kim, Hyeon Chang [2 ,3 ]
机构
[1] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea
关键词
Low-density lipoprotein cholesterol; Cholesterol; Triglyceride; Friedewald formula; DIRECT HOMOGENEOUS ASSAY; LDL-CHOLESTEROL; FRIEDEWALD FORMULA; DIABETES-MELLITUS; MANAGEMENT; REGRESSION; EQUATIONS; VALUES;
D O I
10.4070/kcj.2016.46.5.688
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Low-density lipoprotein cholesterol (LDL-C), an established cardiovascular risk factor, can be generally determined by calculation from total cholesterol, high-density lipoprotein cholesterol, and triglyceride concentrations. The aim of this study was to compare LDL-C estimations using various formulas with directly measured LDL-C in a community-based group and hospital-based group among the Korean population. Subjects and Methods: A total of 1498 participants were classified into four groups according to triglyceride concentrations as follows: <100, 100-199, 200-299, and >= 300 mg/dL. LDL-C was calculated using the Friedewald, Chen, Vujovic, Hattori, de Cordova, and Anandaraja formulas and directly measured using a homogenous enzymatic method. Pearson's correlation coefficients, intraclass correlation coefficients (ICC), Passing & Bablok regression, and Bland-Altman plots were used to evaluate the performance of six formulas. Results: The Friedewald formula had the highest accuracy (ICC=0.977; 95% confidence interval 0.974-0.979) of all the triglyceride ranges, while the Vujovic formula had the highest accuracy (ICC=0.876; 98.75% confidence interval 0.668-0.951) in people with triglycerides >= 300 mg/dL. The mean difference was the lowest for the Friedewald formula (0.5 mg/dL) and the percentage error was the lowest for the Vujovic formula (30.2%). However, underestimation of the LDL-C formulas increased with triglyceride concentrations. Conclusion: The accuracy of the LDL-C formulas varied considerably with differences in triglyceride concentrations. The Friedewald formula outperformed other formulas for estimating LDL-C against a direct measurement and the Vujovic formula was suitable for hypertriglyceridemic samples; it could be used as an alternative cost-effective tool to measure LDL-C when the direct measurement cannot be afforded.
引用
收藏
页码:688 / 698
页数:11
相关论文
共 50 条
  • [41] An alternative marker of low-density lipoprotein cholesterol in coronary artery disease: non-high-density lipoprotein cholesterol
    Ercan, Mujgan
    Oguz, Esra
    Yilmaz, Fatma Meric
    Bogdaycioglu, Nihal
    Unal, Kubranur
    Sahin, Deniz
    Uysal, Sema
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2015, 45 (01) : 153 - 158
  • [42] Contemporary lipid clinic and achievements in low-density lipoprotein-cholesterol reductions in very high-risk patients
    Larsen, Jens V.
    Martinsen, Morten H.
    Mortensen, Martin B.
    Klausen, Ib C.
    Hedegaard, Berit S.
    DANISH MEDICAL JOURNAL, 2021, 68 (01):
  • [43] Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition
    Martin, Seth S.
    Ditmarsch, Marc
    Simmons, Mark
    Alp, Nicholas
    Turner, Traci
    Davidson, Michael H.
    Kastelein, John J. P.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (02) : 148 - 155
  • [44] Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review
    Eric Bruckert
    Klaus Georg Parhofer
    Jose Ramon Gonzalez-Juanatey
    Børge Nordestgaard
    Marcello Arca
    Periklis Giovas
    Kausik Ray
    Advances in Therapy, 2020, 37 : 1724 - 1736
  • [45] An equation for calculating small dense low-density lipoprotein cholesterol
    Han, Tianjiao
    Piao, Zhe
    Yu, Zhiguo
    Xu, Wanqi
    Cui, Xiaofeng
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [46] Validation of low-density lipoprotein cholesterol equations in pediatric population
    Zararsiz, Gozde Erturk
    Bolat, Serkan
    Cephe, Ahu
    Kochan, Necla
    Yerlita, Serra Ilayda
    Dogan, Halef Okan
    Zararsiz, Gokmen
    PEERJ, 2023, 11
  • [48] Low-Density Lipoprotein Cholesterol, Cardiovascular Risk Factors, and Predicted Risk in Young Adults
    Zheutlin, Alexander R.
    Luebbe, Samuel
    Chaitoff, Alexander
    Stulberg, Eric L.
    Wilkins, John T.
    CLINICAL CARDIOLOGY, 2024, 47 (09)
  • [49] Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting
    Verbeek, Rutger
    Hoogeveen, Renate M.
    Langsted, Anne
    Stiekema, Lotte C. A.
    Verweij, Simone L.
    Hovingh, G. Kees
    Wareham, Nicholas J.
    Khaw, Kay-Tee
    Boekholdt, S. Matthijs
    Nordestgaard, Borge G.
    Stroes, Erik S. G.
    EUROPEAN HEART JOURNAL, 2018, 39 (27) : 2589 - 2596
  • [50] Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study
    Barrios, Vivencio
    Pinto, Xavier
    Escobar, Carlos
    Varona, Jose F. F.
    Gamez, Jose M.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)